News Articles and Montana BioScience Alliance Newsletters
Potential Uses Include: Biomarker of Immunity to SARS-CoV-2; Personalized Approach to Timing COVID-19 Vaccine Boosters; Public Health Surveillance; and Serving as an Endpoint for COVID-19 Vaccine Trials
Their ideas included a virtual reality textbook, a new building material, a food incubator, a device to assist construction workers, various software solutions and a student-focused professional networking platform.
As research programs grow at the University of Montana, a team of vaccine scientists are making headway into long-term COVID-19 prevention and clinical trials for an opioid vaccine.
The Montana BioScience Alliance is pleased to announce that Michelle Hood has been inducted into the 2021 MBA Hall of Fame. Ms. Hood is Executive Vice President and Chief Operating Officer of the American Hospital Association and was instrumental in the formation of the Montana BioScience Alliance.
Soon, someone feeling the need for some extra Z’s may benefit from a wearable device that aids the brain in the biochemical cleansing that leaves a person feeling refreshed after a full night of sleep. As part of the first large-scale study on the effectiveness of the new technology, Montana State University researchers will analyze brain scans of participants who wear a prototype of the device, which works by applying precise electrical stimulation to the brain. The project, which involves multiple universities, […]
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.
The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Tuesday, September 5, 2023.
The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.
The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.
View the Summer 2023 Newsletter now!
View the Spring 2023 Newsletter now!